דינמיקת הכנסות משנה לשנה ב-12 החודשים האחרונים: Rockwell Medical, Inc. (RMTI)

Rockwell Medical, Inc. (RMTI) is scaling the distribution of hemodialysis concentrates by expanding contracts with US clinics. Revenue growth is driven by Triferic supplies to the B2B nephrology segment. The year-over-year percentage growth in sales (over 4 quarters) illustrates this trend, where the -4.00 mark reflects the latest data. The integration of intravenous iron therapy makes the company an indispensable link in the kidney treatment ecosystem.
rockwellmed.com - פילוחים אנליטיים ומדדי מפתח (RMTI)

Rockwell Medical, Inc. (RMTI) bases its business on the supply of dialysis concentrates through long-term contracts with clinics. This year-over-year sales volume growth over the last 12 months measures revenue dynamics, stripping the trend of seasonality and one-off factors. Analyzing this trajectory allows for an assessment of real market share expansion and operational efficiency. It is critical for investors to benchmark this pace against raw material cost control. Stable growth confirms the resilience of the business model.